{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "19",
                "@timestamp": "2023-07-19T06:49:46.000046-04:00",
                "@year": "2023",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "08"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-addon-generated-timestamp": "2023-07-12T11:05:44.640Z",
            "xocs:funding-text": "The authors contributed independently to the completion of this manuscript.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp-car"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "112810147",
                            "@country": "sgp",
                            "city": "Singapore",
                            "organization": [
                                {"$": "The Kidney & Transplant Practice"},
                                {"$": "Mount Elizabeth Novena Hospital"}
                            ],
                            "affiliation-id": {"@afid": "112810147"},
                            "@affiliation-instance-id": "OB2BibRecID-947969508-f5dfb1fe402dfeb9d1b53bdc9e114aa6-1",
                            "ce:source-text": "The Kidney & Transplant Practice, Mount Elizabeth Novena Hospital, Singapore, Singapore"
                        },
                        "author": [{
                            "ce:given-name": "Adrian",
                            "preferred-name": {
                                "ce:given-name": "Adrian",
                                "ce:initials": "A.",
                                "ce:surname": "Liew",
                                "ce:indexed-name": "Liew A."
                            },
                            "@author-instance-id": "OB2BibRecID-947969508-8df44c93636d3a94bca36d37d98e3599-1",
                            "@seq": "1",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Liew",
                            "@auid": "26025668700",
                            "@orcid": "0000-0002-0963-6270",
                            "ce:indexed-name": "Liew A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Indonesia",
                            "@afid": "60069378",
                            "@country": "idn",
                            "city": "Jakarta",
                            "organization": [
                                {"$": "Division of Nephrology and Hypertension"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Faculty of Medicine Universitas Indonesia-Dr Cipto Mangunkusumo Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60069378",
                                "@dptid": "100277496"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947969508-fd46eceebe132dd5c48ac142ed19604d-1",
                            "ce:source-text": "Division of Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Dr Cipto Mangunkusumo Hospital, Jakarta, Indonesia",
                            "@dptid": "100277496"
                        },
                        "author": [{
                            "ce:given-name": "Aida",
                            "preferred-name": {
                                "ce:given-name": "Aida",
                                "ce:initials": "A.",
                                "ce:surname": "Lydia",
                                "ce:indexed-name": "Lydia A."
                            },
                            "@author-instance-id": "OB2BibRecID-947969508-0c3827d3220d42b9175ed06e43367456-1",
                            "@seq": "2",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lydia",
                            "@auid": "8451287200",
                            "@orcid": "0000-0001-5146-0435",
                            "ce:indexed-name": "Lydia A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Philippines",
                            "@afid": "60071489",
                            "@country": "phl",
                            "city": "Manila",
                            "organization": [
                                {"$": "Section of Endocrinology"},
                                {"$": "Diabetes and Metabolism"},
                                {"$": "Department of Medicine"},
                                {"$": "University of Santo Tomas Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60071489",
                                "@dptid": "123956971"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947969508-ccb506fb18d0fd9b62132ff30af77d05-1",
                            "ce:source-text": "Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Santo Tomas Hospital, Manila, Philippines",
                            "@dptid": "123956971"
                        },
                        "author": [{
                            "ce:given-name": "Bien J.",
                            "preferred-name": {
                                "ce:given-name": "Bien J.",
                                "ce:initials": "B.J.",
                                "ce:surname": "Matawaran",
                                "ce:indexed-name": "Matawaran B.J."
                            },
                            "@author-instance-id": "OB2BibRecID-947969508-1b75452ac3d35c9fd98e4cc38bc3c45b-1",
                            "@seq": "3",
                            "ce:initials": "B.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Matawaran",
                            "@auid": "55747531200",
                            "ce:indexed-name": "Matawaran B.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Nephrology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"},
                                {"$": "King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183427"
                                },
                                {"@afid": "60022183"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947969508-23005fcc87b4ef03b33bb16ffcc865f7-1",
                            "ce:source-text": "Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "103183427"
                        },
                        "author": [{
                            "ce:given-name": "Paweena",
                            "preferred-name": {
                                "ce:given-name": "Paweena",
                                "ce:initials": "P.",
                                "ce:surname": "Susantitaphong",
                                "ce:indexed-name": "Susantitaphong P."
                            },
                            "@author-instance-id": "OB2BibRecID-947969508-c4a8293320b34e1477a365bc14e3ab4b-1",
                            "@seq": "4",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Susantitaphong",
                            "@auid": "26025374300",
                            "@orcid": "0000-0001-9813-9219",
                            "ce:indexed-name": "Susantitaphong P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Viet Nam",
                            "@afid": "105305134",
                            "@country": "vnm",
                            "city": "Ho Chi Minh City",
                            "organization": [
                                {"$": "Renal Division"},
                                {"$": "Department of Medicine"},
                                {"$": "University of Medicine and Pharmacy"}
                            ],
                            "affiliation-id": {
                                "@afid": "105305134",
                                "@dptid": "129652296"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947969508-6749d197eac09ec8ce8b385a9c7b6053-1",
                            "ce:source-text": "Renal Division, Department of Medicine, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam",
                            "@dptid": "129652296"
                        },
                        "author": [{
                            "ce:given-name": "Huong Thi Bich",
                            "preferred-name": {
                                "ce:given-name": "Huong Thi Bich",
                                "ce:initials": "H.T.B.",
                                "ce:surname": "Tran",
                                "ce:indexed-name": "Tran H.T.B."
                            },
                            "@author-instance-id": "OB2BibRecID-947969508-659a4579bfe797ecfa7fa2e61f1aee4f-1",
                            "@seq": "5",
                            "ce:initials": "H.T.B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Tran",
                            "@auid": "57212636520",
                            "@orcid": "0000-0001-5361-0636",
                            "ce:indexed-name": "Tran H.T.B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@afid": "60029157",
                            "@country": "mys",
                            "city": "Kuala Lumpur",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "University of Malaya"}
                            ],
                            "affiliation-id": {
                                "@afid": "60029157",
                                "@dptid": "112807595"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947969508-72781adfe91873ac100ab0b2a29b35ec-1",
                            "ce:source-text": "Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia",
                            "@dptid": "112807595"
                        },
                        "author": [{
                            "ce:given-name": "Lee Ling",
                            "preferred-name": {
                                "ce:given-name": "Lee Ling",
                                "ce:initials": "L.L.",
                                "ce:surname": "Lim",
                                "ce:indexed-name": "Lim L.L."
                            },
                            "@author-instance-id": "OB2BibRecID-947969508-ad82231a90a8c2ea4b546176ff578780-1",
                            "@seq": "6",
                            "ce:initials": "L.L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lim",
                            "@auid": "56988527400",
                            "ce:indexed-name": "Lim L.L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "address-part": "SAR",
                            "@afid": "60002798",
                            "@country": "hkg",
                            "organization": [
                                {"$": "Department of Medicine and Therapeutics"},
                                {"$": "The Chinese University of Hong Kong"}
                            ],
                            "affiliation-id": {
                                "@afid": "60002798",
                                "@dptid": "113324909"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-947969508-bdc71d1609e1909355046ce99f697fb9-1",
                            "ce:source-text": "Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China",
                            "@dptid": "113324909"
                        },
                        "author": [{
                            "ce:given-name": "Lee Ling",
                            "preferred-name": {
                                "ce:given-name": "Lee Ling",
                                "ce:initials": "L.L.",
                                "ce:surname": "Lim",
                                "ce:indexed-name": "Lim L.L."
                            },
                            "@author-instance-id": "OB2BibRecID-947969508-ad82231a90a8c2ea4b546176ff578780-1",
                            "@seq": "6",
                            "ce:initials": "L.L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lim",
                            "@auid": "56988527400",
                            "ce:indexed-name": "Lim L.L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "address-part": "SAR",
                            "@afid": "113083378",
                            "@country": "hkg",
                            "organization": {"$": "Asia Diabetes Foundation"},
                            "affiliation-id": {"@afid": "113083378"},
                            "@affiliation-instance-id": "OB2BibRecID-947969508-7909f778a12b9e50ede31e986c8db25d-1",
                            "ce:source-text": "Asia Diabetes Foundation, Hong Kong, SAR, China"
                        },
                        "author": [{
                            "ce:given-name": "Lee Ling",
                            "preferred-name": {
                                "ce:given-name": "Lee Ling",
                                "ce:initials": "L.L.",
                                "ce:surname": "Lim",
                                "ce:indexed-name": "Lim L.L."
                            },
                            "@author-instance-id": "OB2BibRecID-947969508-ad82231a90a8c2ea4b546176ff578780-1",
                            "@seq": "6",
                            "ce:initials": "L.L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Lim",
                            "@auid": "56988527400",
                            "ce:indexed-name": "Lim L.L."
                        }]
                    }
                ],
                "citation-title": "Practical considerations for the use of SGLT-2 inhibitors in the Asia\u2013Pacific countries\u2014An expert consensus statement",
                "abstracts": "Â© 2023 Asian Pacific Society of Nephrology.Recent clinical studies have demonstrated the effectiveness of SGLT-2 inhibitors in reducing the risks of cardiovascular and renal events in both patients with and without type 2 diabetes mellitus. Consequently, many international guidelines have begun advocating for the use of SGLT-2 inhibitors for the purpose of organ protection rather than as simply a glucose-lowering agent. However, despite the consistent clinical benefits and available strong guideline recommendations, the utilization of SGLT-2 inhibitors have been unexpectedly low in many countries, a trend which is much more noticeable in low resource settings. Unfamiliarity with the recent focus in their organ protective role and clinical indications; concerns with potential adverse effects of SGLT-2 inhibitors, including acute kidney injury, genitourinary infections, euglycemic ketoacidosis; and their safety profile in elderly populations have been identified as deterring factors to their more widespread use. This review serves as a practical guide to clinicians managing patients who could benefit from SGLT-2 inhibitors treatment and instill greater confidence in the initiation of these drugs, with the aim of optimizing their utilization rates in high-risk populations.",
                "correspondence": [
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@country": "sgp",
                            "city": "Singapore",
                            "organization": [
                                {"$": "The Kidney & Transplant Practice"},
                                {"$": "Mount Elizabeth Novena Hospital"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947969508-db47825784c0ca1fa95f701835cab606-1",
                            "ce:source-text": "The Kidney & Transplant Practice, Mount Elizabeth Novena Hospital, Singapore, Singapore"
                        },
                        "person": {
                            "ce:given-name": "Adrian",
                            "@author-instance-id": "OB2BibRecID-947969508-101f0e22a7f592d1849aafdaace4a4ca-1",
                            "ce:initials": "A.",
                            "ce:surname": "Liew",
                            "ce:indexed-name": "Liew A."
                        }
                    },
                    {
                        "affiliation": {
                            "country": "Malaysia",
                            "@country": "mys",
                            "city": "Kuala Lumpur",
                            "organization": [
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "University of Malaya"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947969508-6322f5195d11c7cacd60107ca3724cde-1",
                            "ce:source-text": "Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia"
                        },
                        "person": {
                            "ce:given-name": "Lee Ling",
                            "@author-instance-id": "OB2BibRecID-947969508-692bada84608c4cd5a77d52269c828e6-1",
                            "ce:initials": "L.L.",
                            "ce:surname": "Lim",
                            "ce:indexed-name": "Lim L.L."
                        }
                    }
                ],
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "acute kidney injury",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "chronic kidney disease",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "ketosis",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "sodium-glucose transporter 2 inhibitors",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "urinary tract infections",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "re"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1440-1797",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Nephrology",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "28",
                            "@issue": "8"
                        },
                        "pagerange": {
                            "@first": "415",
                            "@last": "424"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Nephrology",
                    "publicationdate": {
                        "month": "08",
                        "year": "2023",
                        "date-text": "August 2023",
                        "day": "01"
                    },
                    "codencode": "NEPHF",
                    "sourcetitle-abbrev": "Nephrology",
                    "@country": "aus",
                    "issn": [
                        {
                            "$": "14401797",
                            "@type": "electronic"
                        },
                        {
                            "$": "13205358",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "John Wiley and Sons Inc"},
                    "@srcid": "20020"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "17",
                                    "classification-description": "Public Health, Social Medicine and Epidemiology"
                                },
                                {
                                    "classification-code": "28",
                                    "classification-description": "Urology and Nephrology"
                                },
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2727"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": {
                                "cas-registry-number": [
                                    {"$": "50-99-7"},
                                    {"$": "84778-64-3"},
                                    {"$": "8027-56-3"}
                                ],
                                "chemical-name": "glucose"
                            }
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Blood Glucose"},
                                {"chemical-name": "Hypoglycemic Agents"},
                                {"chemical-name": "Sodium-Glucose Transporter 2 Inhibitors"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The authors contributed independently to the completion of this manuscript.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "18",
                    "@timestamp": "BST 13:53:19",
                    "@year": "2023",
                    "@month": "07"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2023113692",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "947969508",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230428971",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "37153973",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20231285182",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20231707357",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20239014109436",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85158094986",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85158094986",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "641276201",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "77006899",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1111/nep.14167"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "64",
                "reference": [
                    {
                        "ref-fulltext": "Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380(4):347-357.",
                        "@reference-instance-id": "OB2BibRecID-947969508-bb4c93b33cb16615afd061dc9f15481e-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Dapagliflozin and cardiovascular outcomes in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85060042753",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "380",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "347",
                                    "@last": "357"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Wiviott",
                                        "ce:indexed-name": "Wiviott S.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Raz",
                                        "ce:indexed-name": "Raz I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Bonaca",
                                        "ce:indexed-name": "Bonaca M.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Wiviott SD, Raz I, Bonaca MP, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019;380(4):347-357."
                    },
                    {
                        "ref-fulltext": "Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644-657.",
                        "@reference-instance-id": "OB2BibRecID-947969508-bcec55c8b663fed49c103738c6532c9c-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Canagliflozin and cardiovascular and renal events in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85034766786",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "377",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "644",
                                    "@last": "657"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Neal",
                                        "ce:indexed-name": "Neal B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Perkovic",
                                        "ce:indexed-name": "Perkovic V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Mahaffey",
                                        "ce:indexed-name": "Mahaffey K.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377(7):644-657."
                    },
                    {
                        "ref-fulltext": "Perkovic V, de Zeeuw D, Mahaffey KW, et al. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS program randomised clinical trials. Lancet Diabetes Endocrinol. 2018;6(9):691-704.",
                        "@reference-instance-id": "OB2BibRecID-947969508-8bc4771d3bea019e892979719bc646bf-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS program randomised clinical trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85048935795",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "6",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "691",
                                    "@last": "704"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Perkovic",
                                        "ce:indexed-name": "Perkovic V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "de Zeeuw",
                                        "ce:indexed-name": "de Zeeuw D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Mahaffey",
                                        "ce:indexed-name": "Mahaffey K.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Diabetes Endocrinol"
                        },
                        "ce:source-text": "Perkovic V, de Zeeuw D, Mahaffey KW, et al. Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS program randomised clinical trials. Lancet Diabetes Endocrinol. 2018;6(9):691-704."
                    },
                    {
                        "ref-fulltext": "Mahaffey KW, Neal B, Perkovic V, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin cardiovascular assessment study). Circulation. 2018;137(4):323-334.",
                        "@reference-instance-id": "OB2BibRecID-947969508-25dc70583b4446f0a7ab0ea116f6bb05-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin cardiovascular assessment study)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85048449544",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "137",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "323",
                                    "@last": "334"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Mahaffey",
                                        "ce:indexed-name": "Mahaffey K.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Neal",
                                        "ce:indexed-name": "Neal B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Perkovic",
                                        "ce:indexed-name": "Perkovic V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Mahaffey KW, Neal B, Perkovic V, et al. Canagliflozin for primary and secondary prevention of cardiovascular events: results from the CANVAS program (Canagliflozin cardiovascular assessment study). Circulation. 2018;137(4):323-334."
                    },
                    {
                        "ref-fulltext": "Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380(24):2295-2306.",
                        "@reference-instance-id": "OB2BibRecID-947969508-83b3cd6171fdd7a1987ca77c0dd020a8-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Canagliflozin and renal outcomes in type 2 diabetes and nephropathy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066483412",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "380",
                                    "@issue": "24"
                                },
                                "pagerange": {
                                    "@first": "2295",
                                    "@last": "2306"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Perkovic",
                                        "ce:indexed-name": "Perkovic V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Jardine",
                                        "ce:indexed-name": "Jardine M.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Neal",
                                        "ce:indexed-name": "Neal B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380(24):2295-2306."
                    },
                    {
                        "ref-fulltext": "Oshima M, Neal B, Toyama T, et al. Different eGFR decline thresholds and renal effects of Canagliflozin: data from the CANVAS program. J Am Soc Nephrol. 2020;31(10):2446-2456.",
                        "@reference-instance-id": "OB2BibRecID-947969508-dcfcb20bea96494da439fdce64460380-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Different eGFR decline thresholds and renal effects of Canagliflozin: data from the CANVAS program"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092281670",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "31",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "2446",
                                    "@last": "2456"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Oshima",
                                        "ce:indexed-name": "Oshima M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Neal",
                                        "ce:indexed-name": "Neal B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Toyama",
                                        "ce:indexed-name": "Toyama T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Am Soc Nephrol"
                        },
                        "ce:source-text": "Oshima M, Neal B, Toyama T, et al. Different eGFR decline thresholds and renal effects of Canagliflozin: data from the CANVAS program. J Am Soc Nephrol. 2020;31(10):2446-2456."
                    },
                    {
                        "ref-fulltext": "Neuen BL, Ohkuma T, Neal B, et al. Relative and absolute risk reductions in cardiovascular and kidney outcomes with Canagliflozin across KDIGO risk categories: findings from the CANVAS program. Am J Kidney Dis. 2021;77(1):23-34.",
                        "@reference-instance-id": "OB2BibRecID-947969508-8a710e1b49897be00a4e71fc67456e46-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Relative and absolute risk reductions in cardiovascular and kidney outcomes with Canagliflozin across KDIGO risk categories: findings from the CANVAS program"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85096096477",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "77",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "23",
                                    "@last": "34"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Neuen",
                                        "ce:indexed-name": "Neuen B.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Ohkuma",
                                        "ce:indexed-name": "Ohkuma T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Neal",
                                        "ce:indexed-name": "Neal B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Kidney Dis"
                        },
                        "ce:source-text": "Neuen BL, Ohkuma T, Neal B, et al. Relative and absolute risk reductions in cardiovascular and kidney outcomes with Canagliflozin across KDIGO risk categories: findings from the CANVAS program. Am J Kidney Dis. 2021;77(1):23-34."
                    },
                    {
                        "ref-fulltext": "Cannon CP, Pratley R, Dagogo-Jack S, et al. Cardiovascular outcomes with Ertugliflozin in type 2 diabetes. N Engl J Med. 2020;383(15):1425-1435.",
                        "@reference-instance-id": "OB2BibRecID-947969508-8caee9a095989d40fc6c47fff67b77d5-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Cardiovascular outcomes with Ertugliflozin in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092567433",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "383",
                                    "@issue": "15"
                                },
                                "pagerange": {
                                    "@first": "1425",
                                    "@last": "1435"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Cannon",
                                        "ce:indexed-name": "Cannon C.P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Pratley",
                                        "ce:indexed-name": "Pratley R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Dagogo-Jack",
                                        "ce:indexed-name": "Dagogo-Jack S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Cannon CP, Pratley R, Dagogo-Jack S, et al. Cardiovascular outcomes with Ertugliflozin in type 2 diabetes. N Engl J Med. 2020;383(15):1425-1435."
                    },
                    {
                        "ref-fulltext": "Cherney DZI, Charbonnel B, Cosentino F, et al. Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial. Diabetologia. 2021;64(6):1256-1267.",
                        "@reference-instance-id": "OB2BibRecID-947969508-2924d184d942604e4e0542eeea7084b2-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85102173835",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "64",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1256",
                                    "@last": "1267"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.Z.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Cherney",
                                        "ce:indexed-name": "Cherney D.Z.I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Charbonnel",
                                        "ce:indexed-name": "Charbonnel B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Cosentino",
                                        "ce:indexed-name": "Cosentino F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetologia"
                        },
                        "ce:source-text": "Cherney DZI, Charbonnel B, Cosentino F, et al. Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial. Diabetologia. 2021;64(6):1256-1267."
                    },
                    {
                        "ref-fulltext": "Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117-2128.",
                        "@reference-instance-id": "OB2BibRecID-947969508-428b9ecbeb8bb537e8eed2e9b8e3b1c9-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84944800184",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "373",
                                    "@issue": "22"
                                },
                                "pagerange": {
                                    "@first": "2117",
                                    "@last": "2128"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Zinman",
                                        "ce:indexed-name": "Zinman B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Wanner",
                                        "ce:indexed-name": "Wanner C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Lachin",
                                        "ce:indexed-name": "Lachin J.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117-2128."
                    },
                    {
                        "ref-fulltext": "Bhatt DL, Szarek M, Pitt B, et al. Sotagliflozin in patients with diabetes and chronic kidney disease. N Engl J Med. 2021;384(2):129-139.",
                        "@reference-instance-id": "OB2BibRecID-947969508-98e1ad742fdf51b4319de1d6bdf1ad5f-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Sotagliflozin in patients with diabetes and chronic kidney disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85099718366",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "384",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "129",
                                    "@last": "139"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Bhatt",
                                        "ce:indexed-name": "Bhatt D.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Szarek",
                                        "ce:indexed-name": "Szarek M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Pitt",
                                        "ce:indexed-name": "Pitt B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Bhatt DL, Szarek M, Pitt B, et al. Sotagliflozin in patients with diabetes and chronic kidney disease. N Engl J Med. 2021;384(2):129-139."
                    },
                    {
                        "ref-fulltext": "Heerspink HJL, Stefansson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436-1446.",
                        "@reference-instance-id": "OB2BibRecID-947969508-a12e387c2276fd57c0fb8a71126cbbae-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Dapagliflozin in patients with chronic kidney disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092598310",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "383",
                                    "@issue": "15"
                                },
                                "pagerange": {
                                    "@first": "1436",
                                    "@last": "1446"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.J.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Heerspink",
                                        "ce:indexed-name": "Heerspink H.J.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Stefansson",
                                        "ce:indexed-name": "Stefansson B.V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Correa-Rotter",
                                        "ce:indexed-name": "Correa-Rotter R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Heerspink HJL, Stefansson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436-1446."
                    },
                    {
                        "ref-fulltext": "The E-KCG, Herrington WG, Staplin N, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117-127.",
                        "@reference-instance-id": "OB2BibRecID-947969508-790130da8b2d2db29c324e63141dac98-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "Empagliflozin in patients with chronic kidney disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85146258777",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "388",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "117",
                                    "@last": "127"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.-K.C.G.",
                                        "@_fa": "true",
                                        "ce:surname": "The",
                                        "ce:indexed-name": "The E.-K.C.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "W.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Herrington",
                                        "ce:indexed-name": "Herrington W.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Staplin",
                                        "ce:indexed-name": "Staplin N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "The E-KCG, Herrington WG, Staplin N, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117-127."
                    },
                    {
                        "ref-fulltext": "Neuen BL, Oshima M, Perkovic V, et al. Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial. Eur Heart J. 2021;42(48):4891-4901.",
                        "@reference-instance-id": "OB2BibRecID-947969508-a23c30598a38a5a296b6f6f87cbfd331-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85117530666",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "42",
                                    "@issue": "48"
                                },
                                "pagerange": {
                                    "@first": "4891",
                                    "@last": "4901"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Neuen",
                                        "ce:indexed-name": "Neuen B.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Oshima",
                                        "ce:indexed-name": "Oshima M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Perkovic",
                                        "ce:indexed-name": "Perkovic V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur Heart J"
                        },
                        "ce:source-text": "Neuen BL, Oshima M, Perkovic V, et al. Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial. Eur Heart J. 2021;42(48):4891-4901."
                    },
                    {
                        "ref-fulltext": "Neuen BL, Oshima M, Agarwal R, et al. Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials. Circulation. 2022;145(19):1460-1470.",
                        "@reference-instance-id": "OB2BibRecID-947969508-35d0bf7c60266a88ad6cf315db70b312-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85130001554",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "145",
                                    "@issue": "19"
                                },
                                "pagerange": {
                                    "@first": "1460",
                                    "@last": "1470"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Neuen",
                                        "ce:indexed-name": "Neuen B.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Oshima",
                                        "ce:indexed-name": "Oshima M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Agarwal",
                                        "ce:indexed-name": "Agarwal R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Neuen BL, Oshima M, Agarwal R, et al. Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials. Circulation. 2022;145(19):1460-1470."
                    },
                    {
                        "ref-fulltext": "Mahtta D, Ramsey DJ, Lee MT, et al. Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the Department of Veterans Affairs. Diabetes Care. 2022;45(2):372-380.",
                        "@reference-instance-id": "OB2BibRecID-947969508-b0329f9d4106726bd7833320407755c7-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the Department of Veterans Affairs"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85123249290",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "45",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "372",
                                    "@last": "380"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Mahtta",
                                        "ce:indexed-name": "Mahtta D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ramsey",
                                        "ce:indexed-name": "Ramsey D.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee M.T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Mahtta D, Ramsey DJ, Lee MT, et al. Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the Department of Veterans Affairs. Diabetes Care. 2022;45(2):372-380."
                    },
                    {
                        "ref-fulltext": "Arnold SV, Tang F, Cooper A, et al. Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER. BMC Endocr Disord. 2022;22(1):111.",
                        "@reference-instance-id": "OB2BibRecID-947969508-eb6256b0d25e7e259c01749920839729-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85128881633",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "111"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.V.",
                                        "@_fa": "true",
                                        "ce:surname": "Arnold",
                                        "ce:indexed-name": "Arnold S.V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Tang",
                                        "ce:indexed-name": "Tang F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cooper",
                                        "ce:indexed-name": "Cooper A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMC Endocr Disord"
                        },
                        "ce:source-text": "Arnold SV, Tang F, Cooper A, et al. Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER. BMC Endocr Disord. 2022;22(1):111."
                    },
                    {
                        "ref-fulltext": "Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC). Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis. Lancet Diabetes Endocrinol. 2021;9(12):825-836.",
                        "@reference-instance-id": "OB2BibRecID-947969508-41340eb8939365026c17a2398cb98bbe-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85119086457",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "825",
                                    "@last": "836"
                                }
                            },
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC)",
                                "ce:indexed-name": "Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC)"
                            }},
                            "ref-sourcetitle": "Lancet Diabetes Endocrinol"
                        },
                        "ce:source-text": "Global Health & Population Project on Access to Care for Cardiometabolic Diseases (HPACC). Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis. Lancet Diabetes Endocrinol. 2021;9(12):825-836."
                    },
                    {
                        "ref-fulltext": "Jeong SJ, Lee SE, Shin DH, Park IB, Lee HS, Kim KA. Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study. BMC Nephrol. 2021;22(1):177.",
                        "@reference-instance-id": "OB2BibRecID-947969508-db0e84db2843e6b7681cbe804d701eff-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85105852237",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "177"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Jeong",
                                    "ce:indexed-name": "Jeong S.J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee S.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Shin",
                                    "ce:indexed-name": "Shin D.H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "I.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Park",
                                    "ce:indexed-name": "Park I.B."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "H.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee H.S."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "K.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim K.A."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Nephrol"
                        },
                        "ce:source-text": "Jeong SJ, Lee SE, Shin DH, Park IB, Lee HS, Kim KA. Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study. BMC Nephrol. 2021;22(1):177."
                    },
                    {
                        "ref-fulltext": "Joseph JJ, Deedwania P, Acharya T, et al. Comprehensive Management of Cardiovascular Risk Factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation. 2022;145(9):e722-e759.",
                        "@reference-instance-id": "OB2BibRecID-947969508-9fbb8eb796b6f498bcff79c0d4e97b4f-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Comprehensive Management of Cardiovascular Risk Factors for adults with type 2 diabetes: a scientific statement from the American Heart Association"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85125553930",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "145",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "e722",
                                    "@last": "e759"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Joseph",
                                        "ce:indexed-name": "Joseph J.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Deedwania",
                                        "ce:indexed-name": "Deedwania P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Acharya",
                                        "ce:indexed-name": "Acharya T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Joseph JJ, Deedwania P, Acharya T, et al. Comprehensive Management of Cardiovascular Risk Factors for adults with type 2 diabetes: a scientific statement from the American Heart Association. Circulation. 2022;145(9):e722-e759."
                    },
                    {
                        "ref-fulltext": "Chan JCN, Lim LL, Wareham NJ, et al. The lancet commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2021;396(10267):2019-2082.",
                        "@reference-instance-id": "OB2BibRecID-947969508-abf24551649fd838c108bb4e415fdc2d-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "The lancet commission on diabetes: using data to transform diabetes care and patient lives"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85096856701",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "396",
                                    "@issue": "10267"
                                },
                                "pagerange": {
                                    "@first": "2019",
                                    "@last": "2082"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.C.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan J.C.N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim L.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "N.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Wareham",
                                        "ce:indexed-name": "Wareham N.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Chan JCN, Lim LL, Wareham NJ, et al. The lancet commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2021;396(10267):2019-2082."
                    },
                    {
                        "ref-fulltext": "Lim LL, Chow E, Chan JCN. Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice. Nat Rev Endocrinol. 2022;19:151-163.",
                        "@reference-instance-id": "OB2BibRecID-947969508-09c1e0db16b69ef221e6e3cb09bc973f-22",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85142924589",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "151",
                                    "@last": "163"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Lim",
                                    "ce:indexed-name": "Lim L.L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Chow",
                                    "ce:indexed-name": "Chow E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.C.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Chan",
                                    "ce:indexed-name": "Chan J.C.N."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Endocrinol"
                        },
                        "ce:source-text": "Lim LL, Chow E, Chan JCN. Cardiorenal diseases in type 2 diabetes mellitus: clinical trials and real-world practice. Nat Rev Endocrinol. 2022;19:151-163."
                    },
                    {
                        "ref-fulltext": "Kosiborod M, Lam CSP, Kohsaka S, et al. Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: The CVD-REAL 2 study. J Am Coll Cardiol. 2018;71(23):2628-2639.",
                        "@reference-instance-id": "OB2BibRecID-947969508-4a72fd50eb08ce7d901a5cd4755b3278-23",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: The CVD-REAL 2 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85047499725",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "71",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "2628",
                                    "@last": "2639"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kosiborod",
                                        "ce:indexed-name": "Kosiborod M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.S.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Lam",
                                        "ce:indexed-name": "Lam C.S.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Kohsaka",
                                        "ce:indexed-name": "Kohsaka S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Am Coll Cardiol"
                        },
                        "ce:source-text": "Kosiborod M, Lam CSP, Kohsaka S, et al. Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: The CVD-REAL 2 study. J Am Coll Cardiol. 2018;71(23):2628-2639."
                    },
                    {
                        "ref-fulltext": "Udell JA, Yuan Z, Rush T, Sicignano NM, Galitz M, Rosenthal N. Cardiovascular outcomes and risks after initiation of a sodium glucose cotransporter 2 inhibitor: results from the EASEL population-based cohort study (evidence for cardiovascular outcomes with sodium glucose cotransporter 2 inhibitors in the real world). Circulation. 2018;137(14):1450-1459.",
                        "@reference-instance-id": "OB2BibRecID-947969508-726e4f33a0a396a214d1f8e1067180e8-24",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cardiovascular outcomes and risks after initiation of a sodium glucose cotransporter 2 inhibitor: results from the EASEL population-based cohort study (evidence for cardiovascular outcomes with sodium glucose cotransporter 2 inhibitors in the real world)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85048347907",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "137",
                                    "@issue": "14"
                                },
                                "pagerange": {
                                    "@first": "1450",
                                    "@last": "1459"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Udell",
                                    "ce:indexed-name": "Udell J.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Yuan",
                                    "ce:indexed-name": "Yuan Z."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Rush",
                                    "ce:indexed-name": "Rush T."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "N.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Sicignano",
                                    "ce:indexed-name": "Sicignano N.M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Galitz",
                                    "ce:indexed-name": "Galitz M."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Rosenthal",
                                    "ce:indexed-name": "Rosenthal N."
                                }
                            ]},
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Udell JA, Yuan Z, Rush T, Sicignano NM, Galitz M, Rosenthal N. Cardiovascular outcomes and risks after initiation of a sodium glucose cotransporter 2 inhibitor: results from the EASEL population-based cohort study (evidence for cardiovascular outcomes with sodium glucose cotransporter 2 inhibitors in the real world). Circulation. 2018;137(14):1450-1459."
                    },
                    {
                        "ref-fulltext": "Patorno E, Pawar A, Wexler DJ, et al. Effectiveness and safety of empagliflozin in routine care patients: results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study. Diabetes Obes Metab. 2022;24(3):442-454.",
                        "@reference-instance-id": "OB2BibRecID-947969508-54d61cb16b93dbaecf3cac531b650c0e-25",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Effectiveness and safety of empagliflozin in routine care patients: results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85120376560",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "442",
                                    "@last": "454"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Patorno",
                                        "ce:indexed-name": "Patorno E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Pawar",
                                        "ce:indexed-name": "Pawar A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Wexler",
                                        "ce:indexed-name": "Wexler D.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Obes Metab"
                        },
                        "ce:source-text": "Patorno E, Pawar A, Wexler DJ, et al. Effectiveness and safety of empagliflozin in routine care patients: results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study. Diabetes Obes Metab. 2022;24(3):442-454."
                    },
                    {
                        "ref-fulltext": "Group E-KC, Herrington WG, Staplin N, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117-127.",
                        "@reference-instance-id": "OB2BibRecID-947969508-e98939a3884afcff275c6b9e856feca1-26",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "Empagliflozin in patients with chronic kidney disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85146258777",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "388",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "117",
                                    "@last": "127"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Herrington",
                                        "ce:indexed-name": "Herrington W.G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Staplin",
                                        "ce:indexed-name": "Staplin N."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "Group E-KC",
                                    "ce:indexed-name": "Group E-KC"
                                },
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Group E-KC, Herrington WG, Staplin N, et al. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117-127."
                    },
                    {
                        "ref-fulltext": "Rossing P, Caramori ML, Chan JCN, et al. Executive summary of the KDIGO 2022 clinical practice guideline for diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney Int. 2022;102(5):990-999.",
                        "@reference-instance-id": "OB2BibRecID-947969508-5c80215fbbe2ad9cb85e9a5c7bb341cd-27",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Executive summary of the KDIGO 2022 clinical practice guideline for diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0027",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85140015712",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "102",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "990",
                                    "@last": "999"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Rossing",
                                        "ce:indexed-name": "Rossing P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Caramori",
                                        "ce:indexed-name": "Caramori M.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.C.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Chan",
                                        "ce:indexed-name": "Chan J.C.N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Kidney Int"
                        },
                        "ce:source-text": "Rossing P, Caramori ML, Chan JCN, et al. Executive summary of the KDIGO 2022 clinical practice guideline for diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney Int. 2022;102(5):990-999."
                    },
                    {
                        "ref-fulltext": "Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America guideline for the Management of Heart Failure: executive summary. J Card Fail. 2022;28(5):810-830.",
                        "@reference-instance-id": "OB2BibRecID-947969508-59565d0361bc4b4117c28c5058615a14-28",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "2022 American College of Cardiology/American Heart Association/Heart Failure Society of America guideline for the Management of Heart Failure: executive summary"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0028",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85129961740",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "810",
                                    "@last": "830"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Heidenreich",
                                        "ce:indexed-name": "Heidenreich P.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Bozkurt",
                                        "ce:indexed-name": "Bozkurt B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Aguilar",
                                        "ce:indexed-name": "Aguilar D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Card Fail"
                        },
                        "ce:source-text": "Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America guideline for the Management of Heart Failure: executive summary. J Card Fail. 2022;28(5):810-830."
                    },
                    {
                        "ref-fulltext": "American Diabetes Association Professional Practice C. 10. Cardiovascular disease and risk management: standards of medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S144-S174.",
                        "@reference-instance-id": "OB2BibRecID-947969508-32efb87dadb5b0cefde76ae324333d6a-29",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "10. Cardiovascular disease and risk management: standards of medical Care in Diabetes-2022"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0029",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85123302897",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "S144",
                                    "@last": "S174"
                                }
                            },
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "American Diabetes Association Professional Practice C",
                                "ce:indexed-name": "American Diabetes Association Professional Practice C"
                            }},
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "American Diabetes Association Professional Practice C. 10. Cardiovascular disease and risk management: standards of medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S144-S174."
                    },
                    {
                        "ref-fulltext": "American Diabetes Association Professional Practice C, Draznin B, Aroda VR, et al. 11. Chronic kidney disease and risk management: standards of medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S175-S184.",
                        "@reference-instance-id": "OB2BibRecID-947969508-a0e5632a04b135885a84e1104ab1b191-30",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "11. Chronic kidney disease and risk management: standards of medical Care in Diabetes-2022"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0030",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85123320959",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "S175",
                                    "@last": "S184"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Draznin",
                                        "ce:indexed-name": "Draznin B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Aroda",
                                        "ce:indexed-name": "Aroda V.R."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "American Diabetes Association Professional Practice C",
                                    "ce:indexed-name": "American Diabetes Association Professional Practice C"
                                },
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "American Diabetes Association Professional Practice C, Draznin B, Aroda VR, et al. 11. Chronic kidney disease and risk management: standards of medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S175-S184."
                    },
                    {
                        "ref-fulltext": "Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with Empagliflozin in heart failure. N Engl J Med. 2020;383(15):1413-1424.",
                        "@reference-instance-id": "OB2BibRecID-947969508-a12f2f4d4600cd02a4e9c55612f34414-31",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Cardiovascular and renal outcomes with Empagliflozin in heart failure"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0031",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85090992310",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "383",
                                    "@issue": "15"
                                },
                                "pagerange": {
                                    "@first": "1413",
                                    "@last": "1424"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Packer",
                                        "ce:indexed-name": "Packer M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Anker",
                                        "ce:indexed-name": "Anker S.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Butler",
                                        "ce:indexed-name": "Butler J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with Empagliflozin in heart failure. N Engl J Med. 2020;383(15):1413-1424."
                    },
                    {
                        "ref-fulltext": "Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a Preserved ejection fraction. N Engl J Med. 2021;385(16):1451-1461.",
                        "@reference-instance-id": "OB2BibRecID-947969508-2efb3d65379a06a0bfdf61cd8659dac5-32",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Empagliflozin in heart failure with a Preserved ejection fraction"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0032",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85114487957",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "385",
                                    "@issue": "16"
                                },
                                "pagerange": {
                                    "@first": "1451",
                                    "@last": "1461"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Anker",
                                        "ce:indexed-name": "Anker S.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Butler",
                                        "ce:indexed-name": "Butler J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Filippatos",
                                        "ce:indexed-name": "Filippatos G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a Preserved ejection fraction. N Engl J Med. 2021;385(16):1451-1461."
                    },
                    {
                        "ref-fulltext": "Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845-854.",
                        "@reference-instance-id": "OB2BibRecID-947969508-7293f55f314d3fff33638fe0d89637fe-33",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0033",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073095324",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "845",
                                    "@last": "854"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Neuen",
                                        "ce:indexed-name": "Neuen B.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Young",
                                        "ce:indexed-name": "Young T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.J.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Heerspink",
                                        "ce:indexed-name": "Heerspink H.J.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Diabetes Endocrinol"
                        },
                        "ce:source-text": "Neuen BL, Young T, Heerspink HJL, et al. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2019;7(11):845-854."
                    },
                    {
                        "ref-fulltext": "Nuffield Department of Population Health Renal Studies G, Consortium SiM-AC-RT. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022;400(10365):1788-1801.",
                        "@reference-instance-id": "OB2BibRecID-947969508-ab307c28044867b9dda3c01fdae83f80-34",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0034",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85141955149",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "400",
                                    "@issue": "10365"
                                },
                                "pagerange": {
                                    "@first": "1788",
                                    "@last": "1801"
                                }
                            },
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Nuffield Department of Population Health Renal Studies G, Consortium SiM-AC-RT",
                                "ce:indexed-name": "Nuffield Department of Population Health Renal Studies G, Consortium SiM-AC-RT"
                            }},
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Nuffield Department of Population Health Renal Studies G, Consortium SiM-AC-RT. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet. 2022;400(10365):1788-1801."
                    },
                    {
                        "ref-fulltext": "Qiu M, Ding LL, Zhang M, Zhou HR. Safety of four SGLT2 inhibitors in three chronic diseases: a meta-analysis of large randomized trials of SGLT2 inhibitors. Diab Vasc Dis Res. 2021;18(2):14791641211011016.",
                        "@reference-instance-id": "OB2BibRecID-947969508-87c45c3f2109593c253ee8113ad80517-35",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Safety of four SGLT2 inhibitors in three chronic diseases: a meta-analysis of large randomized trials of SGLT2 inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0035",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85105152129",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "18",
                                "@issue": "2"
                            }},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Qiu",
                                    "ce:indexed-name": "Qiu M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Ding",
                                    "ce:indexed-name": "Ding L.L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhou",
                                    "ce:indexed-name": "Zhou H.R."
                                }
                            ]},
                            "ref-sourcetitle": "Diab Vasc Dis Res"
                        },
                        "ce:source-text": "Qiu M, Ding LL, Zhang M, Zhou HR. Safety of four SGLT2 inhibitors in three chronic diseases: a meta-analysis of large randomized trials of SGLT2 inhibitors. Diab Vasc Dis Res. 2021;18(2):14791641211011016."
                    },
                    {
                        "ref-fulltext": "Li D, Wang T, Shen S, Fang Z, Dong Y, Tang H. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: a meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2017;19(3):348-355.",
                        "@reference-instance-id": "OB2BibRecID-947969508-15212fa4ae4111216a3a52b21815a610-36",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: a meta-analysis of randomized controlled trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0036",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85007022677",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "348",
                                    "@last": "355"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Li",
                                    "ce:indexed-name": "Li D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Wang",
                                    "ce:indexed-name": "Wang T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Shen",
                                    "ce:indexed-name": "Shen S."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Fang",
                                    "ce:indexed-name": "Fang Z."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Dong",
                                    "ce:indexed-name": "Dong Y."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Tang",
                                    "ce:indexed-name": "Tang H."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Obes Metab"
                        },
                        "ce:source-text": "Li D, Wang T, Shen S, Fang Z, Dong Y, Tang H. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: a meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2017;19(3):348-355."
                    },
                    {
                        "ref-fulltext": "Liu J, Li L, Li S, et al. Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis. Sci Rep. 2017;7(1):2824.",
                        "@reference-instance-id": "OB2BibRecID-947969508-1957f28ddc858e1d07f4bc46384a04c4-37",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0037",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85020394574",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "2824"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Sci Rep"
                        },
                        "ce:source-text": "Liu J, Li L, Li S, et al. Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis. Sci Rep. 2017;7(1):2824."
                    },
                    {
                        "ref-fulltext": "Figueiredo IR, Rose SCP, Freire NB, Patrocinio MS, Pierdona N, Bittencourt RJ. Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review. Rev Assoc Med Bras (1992). 2019;65(2):246-252.",
                        "@reference-instance-id": "OB2BibRecID-947969508-9ca219b6d4489cc3ab0805b8e8d0c491-38",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0038",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85063266949",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "246",
                                    "@last": "252"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "I.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Figueiredo",
                                    "ce:indexed-name": "Figueiredo I.R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.C.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Rose",
                                    "ce:indexed-name": "Rose S.C.P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "N.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Freire",
                                    "ce:indexed-name": "Freire N.B."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Patrocinio",
                                    "ce:indexed-name": "Patrocinio M.S."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Pierdona",
                                    "ce:indexed-name": "Pierdona N."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "R.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Bittencourt",
                                    "ce:indexed-name": "Bittencourt R.J."
                                }
                            ]},
                            "ref-sourcetitle": "Rev Assoc Med Bras (1992)"
                        },
                        "ce:source-text": "Figueiredo IR, Rose SCP, Freire NB, Patrocinio MS, Pierdona N, Bittencourt RJ. Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review. Rev Assoc Med Bras (1992). 2019;65(2):246-252."
                    },
                    {
                        "ref-fulltext": "Puckrin R, Saltiel MP, Reynier P, Azoulay L, Yu OHY, Filion KB. SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetol. 2018;55(5):503-514.",
                        "@reference-instance-id": "OB2BibRecID-947969508-20f2600d6387755d0029de1e88fd7716-39",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0039",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85042540692",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "55",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "503",
                                    "@last": "514"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Puckrin",
                                    "ce:indexed-name": "Puckrin R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Saltiel",
                                    "ce:indexed-name": "Saltiel M.P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Reynier",
                                    "ce:indexed-name": "Reynier P."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Azoulay",
                                    "ce:indexed-name": "Azoulay L."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "O.H.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Yu",
                                    "ce:indexed-name": "Yu O.H.Y."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "K.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Filion",
                                    "ce:indexed-name": "Filion K.B."
                                }
                            ]},
                            "ref-sourcetitle": "Acta Diabetol"
                        },
                        "ce:source-text": "Puckrin R, Saltiel MP, Reynier P, Azoulay L, Yu OHY, Filion KB. SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetol. 2018;55(5):503-514."
                    },
                    {
                        "ref-fulltext": "Borovac JA, Kurir T, Mustapic I, et al. SGLT2 inhibitors and the risk of urinary tract infections in patients with heart failure: a pooled analysis examining safety endpoints. Kardiol Pol. 2022;80(2):198-201.",
                        "@reference-instance-id": "OB2BibRecID-947969508-2da1680361a15ce6f7056c4af488a25b-40",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "SGLT2 inhibitors and the risk of urinary tract infections in patients with heart failure: a pooled analysis examining safety endpoints"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0040",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85125681809",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "80",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "198",
                                    "@last": "201"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Borovac",
                                        "ce:indexed-name": "Borovac J.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kurir",
                                        "ce:indexed-name": "Kurir T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Mustapic",
                                        "ce:indexed-name": "Mustapic I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Kardiol Pol"
                        },
                        "ce:source-text": "Borovac JA, Kurir T, Mustapic I, et al. SGLT2 inhibitors and the risk of urinary tract infections in patients with heart failure: a pooled analysis examining safety endpoints. Kardiol Pol. 2022;80(2):198-201."
                    },
                    {
                        "ref-fulltext": "Dave CV, Schneeweiss S, Kim D, Fralick M, Tong A, Patorno E. Sodium-glucose Cotransporter-2 inhibitors and the risk for severe urinary tract infections: a population-based cohort study. Ann Intern Med. 2019;171(4):248-256.",
                        "@reference-instance-id": "OB2BibRecID-947969508-d3f141728b664ddc55ab8af9348a3626-41",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Sodium-glucose Cotransporter-2 inhibitors and the risk for severe urinary tract infections: a population-based cohort study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0041",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85071875755",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "171",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "248",
                                    "@last": "256"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Dave",
                                    "ce:indexed-name": "Dave C.V."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Schneeweiss",
                                    "ce:indexed-name": "Schneeweiss S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim D."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Fralick",
                                    "ce:indexed-name": "Fralick M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Tong",
                                    "ce:indexed-name": "Tong A."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Patorno",
                                    "ce:indexed-name": "Patorno E."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Intern Med"
                        },
                        "ce:source-text": "Dave CV, Schneeweiss S, Kim D, Fralick M, Tong A, Patorno E. Sodium-glucose Cotransporter-2 inhibitors and the risk for severe urinary tract infections: a population-based cohort study. Ann Intern Med. 2019;171(4):248-256."
                    },
                    {
                        "ref-fulltext": "Lega IC, Bronskill SE, Campitelli MA, et al. Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: a population-based study of older women and men with diabetes. Diabetes Obes Metab. 2019;21(11):2394-2404.",
                        "@reference-instance-id": "OB2BibRecID-947969508-367a43f5aca3cb5aa2d5eac9b4d6fa61-42",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: a population-based study of older women and men with diabetes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0042",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85069880264",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "2394",
                                    "@last": "2404"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lega",
                                        "ce:indexed-name": "Lega I.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Bronskill",
                                        "ce:indexed-name": "Bronskill S.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Campitelli",
                                        "ce:indexed-name": "Campitelli M.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Obes Metab"
                        },
                        "ce:source-text": "Lega IC, Bronskill SE, Campitelli MA, et al. Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: a population-based study of older women and men with diabetes. Diabetes Obes Metab. 2019;21(11):2394-2404."
                    },
                    {
                        "ref-fulltext": "Alkabbani W, Zongo A, Minhas-Sandhu JK, et al. Sodium-glucose Cotransporter-2 inhibitors and urinary tract infections: a propensity score-matched population-based cohort study. Can. J Diabetes. 2022;46(4):392-403 e13.",
                        "@reference-instance-id": "OB2BibRecID-947969508-d23c776a9e81eea52e4f4bb076d02f44-43",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Sodium-glucose Cotransporter-2 inhibitors and urinary tract infections: a propensity score-matched population-based cohort study. Can"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0043",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85129507933",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "46",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "392",
                                    "@last": "403 e13"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Alkabbani",
                                        "ce:indexed-name": "Alkabbani W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Zongo",
                                        "ce:indexed-name": "Zongo A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Minhas-Sandhu",
                                        "ce:indexed-name": "Minhas-Sandhu J.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Diabetes"
                        },
                        "ce:source-text": "Alkabbani W, Zongo A, Minhas-Sandhu JK, et al. Sodium-glucose Cotransporter-2 inhibitors and urinary tract infections: a propensity score-matched population-based cohort study. Can. J Diabetes. 2022;46(4):392-403 e13."
                    },
                    {
                        "ref-fulltext": "Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the Management of Asymptomatic Bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68(10):1611-1615.",
                        "@reference-instance-id": "OB2BibRecID-947969508-9154f8fb4b0db7515d873142076b0efa-44",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Clinical practice guideline for the Management of Asymptomatic Bacteriuria: 2019 update by the Infectious Diseases Society of America"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0044",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85066159305",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "68",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "1611",
                                    "@last": "1615"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Nicolle",
                                        "ce:indexed-name": "Nicolle L.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Gupta",
                                        "ce:indexed-name": "Gupta K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Bradley",
                                        "ce:indexed-name": "Bradley S.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Infect Dis"
                        },
                        "ce:source-text": "Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the Management of Asymptomatic Bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68(10):1611-1615."
                    },
                    {
                        "ref-fulltext": "Johnsson KM, Ptaszynska A, Schmitz B, Sugg J, Parikh SJ, List JF. Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin. J Diabetes Complicat. 2013;27(5):479-484.",
                        "@reference-instance-id": "OB2BibRecID-947969508-f3590d11825a87bedf682b9e4fa9ba0b-45",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0045",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84883799810",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "479",
                                    "@last": "484"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Johnsson",
                                    "ce:indexed-name": "Johnsson K.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Ptaszynska",
                                    "ce:indexed-name": "Ptaszynska A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Schmitz",
                                    "ce:indexed-name": "Schmitz B."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Sugg",
                                    "ce:indexed-name": "Sugg J."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Parikh",
                                    "ce:indexed-name": "Parikh S.J."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "J.F.",
                                    "@_fa": "true",
                                    "ce:surname": "List",
                                    "ce:indexed-name": "List J.F."
                                }
                            ]},
                            "ref-sourcetitle": "J Diabetes Complicat"
                        },
                        "ce:source-text": "Johnsson KM, Ptaszynska A, Schmitz B, Sugg J, Parikh SJ, List JF. Vulvovaginitis and balanitis in patients with diabetes treated with dapagliflozin. J Diabetes Complicat. 2013;27(5):479-484."
                    },
                    {
                        "ref-fulltext": "Zaccardi F, Webb DR, Htike ZZ, Youssef D, Khunti K, Davies MJ. Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis. Diabetes Obes Metab. 2016;18(8):783-794.",
                        "@reference-instance-id": "OB2BibRecID-947969508-34931d14809a09856a031f44bf720014-46",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0046",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84969915634",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "783",
                                    "@last": "794"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Zaccardi",
                                    "ce:indexed-name": "Zaccardi F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Webb",
                                    "ce:indexed-name": "Webb D.R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Z.Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Htike",
                                    "ce:indexed-name": "Htike Z.Z."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Youssef",
                                    "ce:indexed-name": "Youssef D."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Khunti",
                                    "ce:indexed-name": "Khunti K."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Davies",
                                    "ce:indexed-name": "Davies M.J."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Obes Metab"
                        },
                        "ce:source-text": "Zaccardi F, Webb DR, Htike ZZ, Youssef D, Khunti K, Davies MJ. Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis. Diabetes Obes Metab. 2016;18(8):783-794."
                    },
                    {
                        "ref-fulltext": "Kaze AD, Zhuo M, Kim SC, Patorno E, Paik JM. Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis. Cardiovasc Diabetol. 2022;21(1):47.",
                        "@reference-instance-id": "OB2BibRecID-947969508-ded1afd1ded75270f91c46696a8bde1d-47",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0047",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85126850032",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "47"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Kaze",
                                    "ce:indexed-name": "Kaze A.D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhuo",
                                    "ce:indexed-name": "Zhuo M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim S.C."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Patorno",
                                    "ce:indexed-name": "Patorno E."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Paik",
                                    "ce:indexed-name": "Paik J.M."
                                }
                            ]},
                            "ref-sourcetitle": "Cardiovasc Diabetol"
                        },
                        "ce:source-text": "Kaze AD, Zhuo M, Kim SC, Patorno E, Paik JM. Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis. Cardiovasc Diabetol. 2022;21(1):47."
                    },
                    {
                        "ref-fulltext": "Unnikrishnan AG, Kalra S, Purandare V, Vasnawala H. Genital infections with sodium glucose Cotransporter-2 inhibitors: occurrence and Management in Patients with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2018;22(6):837-842.",
                        "@reference-instance-id": "OB2BibRecID-947969508-86ea6f411047d1f291af086419c11b1a-48",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Genital infections with sodium glucose Cotransporter-2 inhibitors: occurrence and Management in Patients with type 2 diabetes mellitus"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0048",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85058631437",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "837",
                                    "@last": "842"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Unnikrishnan",
                                    "ce:indexed-name": "Unnikrishnan A.G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Kalra",
                                    "ce:indexed-name": "Kalra S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Purandare",
                                    "ce:indexed-name": "Purandare V."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Vasnawala",
                                    "ce:indexed-name": "Vasnawala H."
                                }
                            ]},
                            "ref-sourcetitle": "Indian J Endocrinol Metab"
                        },
                        "ce:source-text": "Unnikrishnan AG, Kalra S, Purandare V, Vasnawala H. Genital infections with sodium glucose Cotransporter-2 inhibitors: occurrence and Management in Patients with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2018;22(6):837-842."
                    },
                    {
                        "ref-fulltext": "Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343.",
                        "@reference-instance-id": "OB2BibRecID-947969508-4bad9828eb3cd57b90d7d5e0c2d33278-49",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Hyperglycemic crises in adult patients with diabetes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0049",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "67650080701",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "32",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "1335",
                                    "@last": "1343"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Kitabchi",
                                    "ce:indexed-name": "Kitabchi A.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Umpierrez",
                                    "ce:indexed-name": "Umpierrez G.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Miles",
                                    "ce:indexed-name": "Miles J.M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "J.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Fisher",
                                    "ce:indexed-name": "Fisher J.N."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343."
                    },
                    {
                        "ref-fulltext": "Ogawa W, Sakaguchi K. Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors. J Diabetes Investig. 2016;7(2):135-138.",
                        "@reference-instance-id": "OB2BibRecID-947969508-f51813ec7514637d01ca20eeb14ba3e3-50",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0050",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84959366596",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "7",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "135",
                                    "@last": "138"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Ogawa",
                                    "ce:indexed-name": "Ogawa W."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Sakaguchi",
                                    "ce:indexed-name": "Sakaguchi K."
                                }
                            ]},
                            "ref-sourcetitle": "J Diabetes Investig"
                        },
                        "ce:source-text": "Ogawa W, Sakaguchi K. Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors. J Diabetes Investig. 2016;7(2):135-138."
                    },
                    {
                        "ref-fulltext": "Dawwas GK, Flory JH, Hennessy S, Leonard CE, Lewis JD. Comparative safety of sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors and sulfonylureas on the risk of diabetic ketoacidosis. Diabetes Care. 2022;45(4):919-927.",
                        "@reference-instance-id": "OB2BibRecID-947969508-711b43b5769b6bdaf52bc7a6e2438945-51",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Comparative safety of sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors and sulfonylureas on the risk of diabetic ketoacidosis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0051",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85128159774",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "45",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "919",
                                    "@last": "927"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Dawwas",
                                    "ce:indexed-name": "Dawwas G.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Flory",
                                    "ce:indexed-name": "Flory J.H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Hennessy",
                                    "ce:indexed-name": "Hennessy S."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "C.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Leonard",
                                    "ce:indexed-name": "Leonard C.E."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Lewis",
                                    "ce:indexed-name": "Lewis J.D."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Dawwas GK, Flory JH, Hennessy S, Leonard CE, Lewis JD. Comparative safety of sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors and sulfonylureas on the risk of diabetic ketoacidosis. Diabetes Care. 2022;45(4):919-927."
                    },
                    {
                        "ref-fulltext": "Yu X, Zhang S, Zhang L. Newer perspectives of mechanisms for Euglycemic diabetic ketoacidosis. Int J Endocrinol. 2018;2018:7074868.",
                        "@reference-instance-id": "OB2BibRecID-947969508-1bbfc9861cc8292697fc53f3cfd9fd26-52",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Newer perspectives of mechanisms for Euglycemic diabetic ketoacidosis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0052",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85063234181",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "2018"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Yu",
                                    "ce:indexed-name": "Yu X."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang L."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Endocrinol"
                        },
                        "ce:source-text": "Yu X, Zhang S, Zhang L. Newer perspectives of mechanisms for Euglycemic diabetic ketoacidosis. Int J Endocrinol. 2018;2018:7074868."
                    },
                    {
                        "ref-fulltext": "Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care. 2015;38(9):1638-1642.",
                        "@reference-instance-id": "OB2BibRecID-947969508-e7dc70b4945ce220377bbfa2802c7e8b-53",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0053",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84962439093",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "38",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1638",
                                    "@last": "1642"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Rosenstock",
                                    "ce:indexed-name": "Rosenstock J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Ferrannini",
                                    "ce:indexed-name": "Ferrannini E."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Rosenstock J, Ferrannini E. Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care. 2015;38(9):1638-1642."
                    },
                    {
                        "ref-fulltext": "Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687-1693.",
                        "@reference-instance-id": "OB2BibRecID-947969508-da5be6ada644c85370be6099620c35c1-54",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0054",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84962339296",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "38",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1687",
                                    "@last": "1693"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Peters",
                                    "ce:indexed-name": "Peters A.L."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.O.",
                                    "@_fa": "true",
                                    "ce:surname": "Buschur",
                                    "ce:indexed-name": "Buschur E.O."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Buse",
                                    "ce:indexed-name": "Buse J.B."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Cohan",
                                    "ce:indexed-name": "Cohan P."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "J.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Diner",
                                    "ce:indexed-name": "Diner J.C."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "I.B.",
                                    "@_fa": "true",
                                    "ce:surname": "Hirsch",
                                    "ce:indexed-name": "Hirsch I.B."
                                }
                            ]},
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687-1693."
                    },
                    {
                        "ref-fulltext": "Hassanein M, Bashier A, Randeree H, et al. Use of SGLT2 inhibitors during Ramadan: an expert panel statement. Diabetes Res Clin Pract. 2020;169:108465.",
                        "@reference-instance-id": "OB2BibRecID-947969508-c8d1c68dd1a1a5e7a75aa9c77b5bcec6-55",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Use of SGLT2 inhibitors during Ramadan: an expert panel statement"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0055",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092225947",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "169"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Hassanein",
                                        "ce:indexed-name": "Hassanein M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Bashier",
                                        "ce:indexed-name": "Bashier A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Randeree",
                                        "ce:indexed-name": "Randeree H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Res Clin Pract"
                        },
                        "ce:source-text": "Hassanein M, Bashier A, Randeree H, et al. Use of SGLT2 inhibitors during Ramadan: an expert panel statement. Diabetes Res Clin Pract. 2020;169:108465."
                    },
                    {
                        "ref-fulltext": "Loh HH, Kamaruddin NA. Treatment options for patients with type 2 diabetes mellitus during the fasting month of Ramadan. Ann Acad Med Singap. 2020;49(7):468-476.",
                        "@reference-instance-id": "OB2BibRecID-947969508-e9cd44115ca2d1d179434ada2786f188-56",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Treatment options for patients with type 2 diabetes mellitus during the fasting month of Ramadan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0056",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85092535581",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "49",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "468",
                                    "@last": "476"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Loh",
                                    "ce:indexed-name": "Loh H.H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kamaruddin",
                                    "ce:indexed-name": "Kamaruddin N.A."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Acad Med Singap"
                        },
                        "ce:source-text": "Loh HH, Kamaruddin NA. Treatment options for patients with type 2 diabetes mellitus during the fasting month of Ramadan. Ann Acad Med Singap. 2020;49(7):468-476."
                    },
                    {
                        "ref-fulltext": "Gad H, Al-Nassr N, Mohammed I, et al. Effect of Ramadan fasting in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitors: a systematic review and meta-analysis. J Diabetes Investig. 2022;13(5):822-829.",
                        "@reference-instance-id": "OB2BibRecID-947969508-e528eb2dd5512d70e6189b63be18477f-57",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Effect of Ramadan fasting in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitors: a systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0057",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85122759717",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "13",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "822",
                                    "@last": "829"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Gad",
                                        "ce:indexed-name": "Gad H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Al-Nassr",
                                        "ce:indexed-name": "Al-Nassr N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Mohammed",
                                        "ce:indexed-name": "Mohammed I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Diabetes Investig"
                        },
                        "ce:source-text": "Gad H, Al-Nassr N, Mohammed I, et al. Effect of Ramadan fasting in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitors: a systematic review and meta-analysis. J Diabetes Investig. 2022;13(5):822-829."
                    },
                    {
                        "ref-fulltext": "Cintra R, Moura FA, Carvalho LSF, et al. Inhibition of the sodium-glucose co-transporter 2 in the elderly: clinical and mechanistic insights into safety and efficacy. Rev Assoc Med Bras. 1992;65(1):70-86.",
                        "@reference-instance-id": "OB2BibRecID-947969508-a5f950a12d5bc9b12c951af3d1f69ae0-58",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1992"},
                            "ref-title": {"ref-titletext": "Inhibition of the sodium-glucose co-transporter 2 in the elderly: clinical and mechanistic insights into safety and efficacy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0058",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85061490065",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "70",
                                    "@last": "86"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Cintra",
                                        "ce:indexed-name": "Cintra R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Moura",
                                        "ce:indexed-name": "Moura F.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.S.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Carvalho",
                                        "ce:indexed-name": "Carvalho L.S.F."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Rev Assoc Med Bras"
                        },
                        "ce:source-text": "Cintra R, Moura FA, Carvalho LSF, et al. Inhibition of the sodium-glucose co-transporter 2 in the elderly: clinical and mechanistic insights into safety and efficacy. Rev Assoc Med Bras. 1992;65(1):70-86."
                    },
                    {
                        "ref-fulltext": "Miller EM. Elements for success in managing type 2 diabetes with SGLT-2 inhibitors: individualizing treatment with SGLT-2 inhibitor therapy in type 2 diabetes mellitus. J Fam Pract. 2017;66(2 Suppl):S13-S16.",
                        "@reference-instance-id": "OB2BibRecID-947969508-27981a8f71759a17c1a49531c8c73940-59",
                        "@id": "59",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Elements for success in managing type 2 diabetes with SGLT-2 inhibitors: individualizing treatment with SGLT-2 inhibitor therapy in type 2 diabetes mellitus"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0059",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85021857486",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "66",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "S13",
                                    "@last": "S16"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "E.M.",
                                "@_fa": "true",
                                "ce:surname": "Miller",
                                "ce:indexed-name": "Miller E.M."
                            }]},
                            "ref-sourcetitle": "J Fam Pract"
                        },
                        "ce:source-text": "Miller EM. Elements for success in managing type 2 diabetes with SGLT-2 inhibitors: individualizing treatment with SGLT-2 inhibitor therapy in type 2 diabetes mellitus. J Fam Pract. 2017;66(2 Suppl):S13-S16."
                    },
                    {
                        "ref-fulltext": "Fioretto P, Mansfield TA, Ptaszynska A, Yavin Y, Johnsson E, Parikh S. Long-term safety of Dapagliflozin in older patients with type 2 diabetes mellitus: a pooled analysis of phase IIb/III studies. Drugs Aging. 2016;33(7):511-522.",
                        "@reference-instance-id": "OB2BibRecID-947969508-b8ca4182873088f5d95ba7688c1b3741-60",
                        "@id": "60",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Long-term safety of Dapagliflozin in older patients with type 2 diabetes mellitus: a pooled analysis of phase IIb/III studies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0060",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84976421792",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "33",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "511",
                                    "@last": "522"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Fioretto",
                                    "ce:indexed-name": "Fioretto P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Mansfield",
                                    "ce:indexed-name": "Mansfield T.A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Ptaszynska",
                                    "ce:indexed-name": "Ptaszynska A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Yavin",
                                    "ce:indexed-name": "Yavin Y."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Johnsson",
                                    "ce:indexed-name": "Johnsson E."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Parikh",
                                    "ce:indexed-name": "Parikh S."
                                }
                            ]},
                            "ref-sourcetitle": "Drugs Aging"
                        },
                        "ce:source-text": "Fioretto P, Mansfield TA, Ptaszynska A, Yavin Y, Johnsson E, Parikh S. Long-term safety of Dapagliflozin in older patients with type 2 diabetes mellitus: a pooled analysis of phase IIb/III studies. Drugs Aging. 2016;33(7):511-522."
                    },
                    {
                        "ref-fulltext": "Monteiro P, Bergenstal RM, Toural E, et al. Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME(R) trial. Age Ageing. 2019;48(6):859-866.",
                        "@reference-instance-id": "OB2BibRecID-947969508-809f4b5b42554ca87fe1473937ffa698-61",
                        "@id": "61",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME(R) trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0061",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074184359",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "48",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "859",
                                    "@last": "866"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Monteiro",
                                        "ce:indexed-name": "Monteiro P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Bergenstal",
                                        "ce:indexed-name": "Bergenstal R.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Toural",
                                        "ce:indexed-name": "Toural E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Age Ageing"
                        },
                        "ce:source-text": "Monteiro P, Bergenstal RM, Toural E, et al. Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME(R) trial. Age Ageing. 2019;48(6):859-866."
                    },
                    {
                        "ref-fulltext": "Johnsson K, Johnsson E, Mansfield TA, Yavin Y, Ptaszynska A, Parikh SJ. Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials. Postgrad Med. 2016;128(4):346-355.",
                        "@reference-instance-id": "OB2BibRecID-947969508-fd03ff06b61291efc37029f9c0c396b2-62",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0062",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84978402704",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "128",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "346",
                                    "@last": "355"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Johnsson",
                                    "ce:indexed-name": "Johnsson K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Johnsson",
                                    "ce:indexed-name": "Johnsson E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Mansfield",
                                    "ce:indexed-name": "Mansfield T.A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Yavin",
                                    "ce:indexed-name": "Yavin Y."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Ptaszynska",
                                    "ce:indexed-name": "Ptaszynska A."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "S.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Parikh",
                                    "ce:indexed-name": "Parikh S.J."
                                }
                            ]},
                            "ref-sourcetitle": "Postgrad Med"
                        },
                        "ce:source-text": "Johnsson K, Johnsson E, Mansfield TA, Yavin Y, Ptaszynska A, Parikh SJ. Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials. Postgrad Med. 2016;128(4):346-355."
                    },
                    {
                        "ref-fulltext": "McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995-2008.",
                        "@reference-instance-id": "OB2BibRecID-947969508-0fe5129b0919fa353bbd6572b1493123-63",
                        "@id": "63",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Dapagliflozin in patients with heart failure and reduced ejection fraction"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0063",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073118508",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "381",
                                    "@issue": "21"
                                },
                                "pagerange": {
                                    "@first": "1995",
                                    "@last": "2008"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.J.V.",
                                        "@_fa": "true",
                                        "ce:surname": "McMurray",
                                        "ce:indexed-name": "McMurray J.J.V."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Solomon",
                                        "ce:indexed-name": "Solomon S.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Inzucchi",
                                        "ce:indexed-name": "Inzucchi S.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995-2008."
                    },
                    {
                        "ref-fulltext": "Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387(12):1089-1098.",
                        "@reference-instance-id": "OB2BibRecID-947969508-6e8ba3920a8581af710db9fb3f142f45-64",
                        "@id": "64",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "nep14167-cit-0064",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85138185629",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "387",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1089",
                                    "@last": "1098"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Solomon",
                                        "ce:indexed-name": "Solomon S.D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.J.V.",
                                        "@_fa": "true",
                                        "ce:surname": "McMurray",
                                        "ce:indexed-name": "McMurray J.J.V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Claggett",
                                        "ce:indexed-name": "Claggett B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Solomon SD, McMurray JJV, Claggett B, et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387(12):1089-1098."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Manila",
            "@id": "60071489",
            "affilname": "University of Santo Tomas Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071489",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Central Jakarta",
            "@id": "60069378",
            "affilname": "Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069378",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "@id": "60029157",
            "affilname": "Universiti Malaya",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029157",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60002798",
            "affilname": "Chinese University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002798",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "113083378",
            "affilname": "Asia Diabetes Foundation",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113083378",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "112810147",
            "affilname": "Mount Elizabeth Novena Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112810147",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Ho Chi Minh City",
            "@id": "105305134",
            "affilname": "University of Medicine and Pharmacy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/105305134",
            "affiliation-country": "Viet Nam"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85158094986",
        "dc:description": "Recent clinical studies have demonstrated the effectiveness of SGLT-2 inhibitors in reducing the risks of cardiovascular and renal events in both patients with and without type 2 diabetes mellitus. Consequently, many international guidelines have begun advocating for the use of SGLT-2 inhibitors for the purpose of organ protection rather than as simply a glucose-lowering agent. However, despite the consistent clinical benefits and available strong guideline recommendations, the utilization of SGLT-2 inhibitors have been unexpectedly low in many countries, a trend which is much more noticeable in low resource settings. Unfamiliarity with the recent focus in their organ protective role and clinical indications; concerns with potential adverse effects of SGLT-2 inhibitors, including acute kidney injury, genitourinary infections, euglycemic ketoacidosis; and their safety profile in elderly populations have been identified as deterring factors to their more widespread use. This review serves as a practical guide to clinicians managing patients who could benefit from SGLT-2 inhibitors treatment and instill greater confidence in the initiation of these drugs, with the aim of optimizing their utilization rates in high-risk populations.",
        "pubmed-id": "37153973",
        "prism:coverDate": "2023-08-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85158094986",
        "dc:creator": {"author": [{
            "ce:given-name": "Adrian",
            "preferred-name": {
                "ce:given-name": "Adrian",
                "ce:initials": "A.",
                "ce:surname": "Liew",
                "ce:indexed-name": "Liew A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "112810147",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112810147"
            },
            "ce:surname": "Liew",
            "@auid": "26025668700",
            "author-url": "https://api.elsevier.com/content/author/author_id/26025668700",
            "ce:indexed-name": "Liew A."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85158094986"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85158094986&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85158094986&origin=inward"
            }
        ],
        "source-id": "20020",
        "citedby-count": "0",
        "prism:volume": "28",
        "subtype": "re",
        "dc:title": "Practical considerations for the use of SGLT-2 inhibitors in the Asia\u2013Pacific countries\u2014An expert consensus statement",
        "openaccess": "1",
        "prism:issn": "14401797 13205358",
        "publishercopyright": "Â© 2023 Asian Pacific Society of Nephrology.",
        "prism:issueIdentifier": "8",
        "subtypeDescription": "Review",
        "prism:publicationName": "Nephrology",
        "prism:pageRange": "415-424",
        "prism:endingPage": "424",
        "openaccessFlag": "true",
        "prism:doi": "10.1111/nep.14167",
        "prism:startingPage": "415",
        "dc:identifier": "SCOPUS_ID:85158094986",
        "dc:publisher": "John Wiley and Sons Inc"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Blood Glucose",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Diabetes Mellitus, Type 2",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Hypoglycemic Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Risk Factors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Sodium-Glucose Transporter 2 Inhibitors",
            "@weight": "a",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "acute kidney injury"
        },
        {
            "@_fa": "true",
            "$": "chronic kidney disease"
        },
        {
            "@_fa": "true",
            "$": "ketosis"
        },
        {
            "@_fa": "true",
            "$": "sodium-glucose transporter 2 inhibitors"
        },
        {
            "@_fa": "true",
            "$": "urinary tract infections"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Nephrology",
        "@code": "2727",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Adrian",
            "preferred-name": {
                "ce:given-name": "Adrian",
                "ce:initials": "A.",
                "ce:surname": "Liew",
                "ce:indexed-name": "Liew A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "112810147",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112810147"
            },
            "ce:surname": "Liew",
            "@auid": "26025668700",
            "author-url": "https://api.elsevier.com/content/author/author_id/26025668700",
            "ce:indexed-name": "Liew A."
        },
        {
            "ce:given-name": "Aida",
            "preferred-name": {
                "ce:given-name": "Aida",
                "ce:initials": "A.",
                "ce:surname": "Lydia",
                "ce:indexed-name": "Lydia A."
            },
            "@seq": "2",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60069378",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069378"
            },
            "ce:surname": "Lydia",
            "@auid": "8451287200",
            "author-url": "https://api.elsevier.com/content/author/author_id/8451287200",
            "ce:indexed-name": "Lydia A."
        },
        {
            "ce:given-name": "Bien J.",
            "preferred-name": {
                "ce:given-name": "Bien J.",
                "ce:initials": "B.J.",
                "ce:surname": "Matawaran",
                "ce:indexed-name": "Matawaran B.J."
            },
            "@seq": "3",
            "ce:initials": "B.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60071489",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071489"
            },
            "ce:surname": "Matawaran",
            "@auid": "55747531200",
            "author-url": "https://api.elsevier.com/content/author/author_id/55747531200",
            "ce:indexed-name": "Matawaran B.J."
        },
        {
            "ce:given-name": "Paweena",
            "preferred-name": {
                "ce:given-name": "Paweena",
                "ce:initials": "P.",
                "ce:surname": "Susantitaphong",
                "ce:indexed-name": "Susantitaphong P."
            },
            "@seq": "4",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Susantitaphong",
            "@auid": "26025374300",
            "author-url": "https://api.elsevier.com/content/author/author_id/26025374300",
            "ce:indexed-name": "Susantitaphong P."
        },
        {
            "ce:given-name": "Huong Thi Bich",
            "preferred-name": {
                "ce:given-name": "Huong Thi Bich",
                "ce:initials": "H.T.B.",
                "ce:surname": "Tran",
                "ce:indexed-name": "Tran H.T.B."
            },
            "@seq": "5",
            "ce:initials": "H.T.B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "105305134",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/105305134"
            },
            "ce:surname": "Tran",
            "@auid": "57212636520",
            "author-url": "https://api.elsevier.com/content/author/author_id/57212636520",
            "ce:indexed-name": "Tran H.T.B."
        },
        {
            "ce:given-name": "Lee Ling",
            "preferred-name": {
                "ce:given-name": "Lee Ling",
                "ce:initials": "L.L.",
                "ce:surname": "Lim",
                "ce:indexed-name": "Lim L.L."
            },
            "@seq": "6",
            "ce:initials": "L.L.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60029157",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029157"
                },
                {
                    "@id": "60002798",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002798"
                },
                {
                    "@id": "113083378",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/113083378"
                }
            ],
            "ce:surname": "Lim",
            "@auid": "56988527400",
            "author-url": "https://api.elsevier.com/content/author/author_id/56988527400",
            "ce:indexed-name": "Lim L.L."
        }
    ]}
}}